International Stem Cell Corp (ISCO)
0.0712
0.00 (0.00%)
USD |
OTCM |
Apr 19, 16:00
International Stem Cell Cash from Operations (Quarterly): 0.161M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.161M |
| September 30, 2023 | 0.062M |
| June 30, 2023 | 0.49M |
| March 31, 2023 | 0.216M |
| December 31, 2022 | 0.079M |
| September 30, 2022 | 0.084M |
| June 30, 2022 | 0.192M |
| March 31, 2022 | -0.023M |
| December 31, 2021 | -0.316M |
| September 30, 2021 | -0.224M |
| June 30, 2021 | -0.363M |
| March 31, 2021 | -0.394M |
| December 31, 2020 | -0.311M |
| September 30, 2020 | -0.277M |
| June 30, 2020 | -0.018M |
| March 31, 2020 | 0.265M |
| December 31, 2019 | -0.381M |
| September 30, 2019 | -0.027M |
| June 30, 2019 | -0.648M |
| March 31, 2019 | -0.341M |
| December 31, 2018 | 0.034M |
| September 30, 2018 | -0.558M |
| June 30, 2018 | -0.51M |
| March 31, 2018 | -0.048M |
| December 31, 2017 | -0.493M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.319M |
| June 30, 2017 | -0.759M |
| March 31, 2017 | -0.571M |
| December 31, 2016 | -0.939M |
| September 30, 2016 | -0.426M |
| June 30, 2016 | -0.863M |
| March 31, 2016 | -1.969M |
| December 31, 2015 | -0.674M |
| September 30, 2015 | -0.558M |
| June 30, 2015 | -2.124M |
| March 31, 2015 | -0.764M |
| December 31, 2014 | -1.961M |
| September 30, 2014 | -1.097M |
| June 30, 2014 | -1.326M |
| March 31, 2014 | -2.031M |
| December 31, 2013 | -1.405M |
| September 30, 2013 | -1.34M |
| June 30, 2013 | -1.046M |
| March 31, 2013 | -1.847M |
| December 31, 2012 | -1.57M |
| September 30, 2012 | -1.659M |
| June 30, 2012 | -1.435M |
| March 31, 2012 | -2.025M |
| December 31, 2011 | -1.43M |
| September 30, 2011 | -2.563M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-0.648M
Minimum
Jun 2019
0.49M
Maximum
Jun 2023
-0.0754M
Average
-0.023M
Median
Mar 2022
Cash from Operations (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -9.758M |
| Perspective Therapeutics Inc | -9.008M |
| Protalix BioTherapeutics Inc | 3.595M |
| Electromed Inc | 3.471M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.003M |
| Free Cash Flow | 0.846M |
| Free Cash Flow Per Share (Quarterly) | 0.0197 |
| Free Cash Flow to Equity (Quarterly) | 0.125M |
| Free Cash Flow Yield | 148.4% |